To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder

Exclusion Criteria

• •1. Individuals diagnosed by the Investigator with the following conditions (current unless otherwise stated):
• •* History of open skull traumatic brain injury
• •* History of clinically significant seizure disorder
• •2. Individuals with a clinically defined neurological disorder including, but not limited to:
• •* Any condition likely to be associated with increased intracranial pressure
• •* Space occupying brain lesion
• •* History of cerebrovascular accident
• •* Cerebral aneurysm
• •3. Abnormalities that indicate risk of seizure, i.e., focal or general slowing or spikes during EEG recording
• •4. Any type of rTMS treatment within 3 months prior to the screening visit
• •5. Currently under antipsychotic medication treatment
• •6. Intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants, stents, or electrodes) or any other metal object within or near the head, excluding the mouth, which cannot be safely removed
• •7. Clinically significant abnormality or clinically significant unstable medical condition that in the Investigator's judgment might pose a potential safety risk to the subject or limit interpretation of the trial results
• •8. Clinically significant medical illness, including any uncontrolled thyroid disorders, hepatic, cardiac, pulmonary and renal malfunctioning
• •9. Any condition which in the judgment of the investigator would prevent the subject from completion of the study
• •10. Inability to acquire a clinically satisfactory EEG/ECG on a routine basis
• •11. Grossly abnormal electrolyte or cell blood count panels suggestive of other pathology at study initiation
• •12. Pregnant or breastfeeding women